Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
319
datasets available to search
ShareScore release 0.7.1
Dataset results
319 results for “Cell biology”
Study of Biological Markers in Children With Sickle Cell Disease
ClinicalTrials.gov study NCT04839159. IPD Sharing: NO. Countries: 1. Publications: 11.
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov study NCT00008203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease
ClinicalTrials.gov study NCT02285088. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
ClinicalTrials.gov study NCT02899039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00499577. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma
ClinicalTrials.gov study NCT02402842. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Raw data for the paper on biological autoluminescence from yeast cells culture
<p>raw data of the paper on biological autoluminescence from yeast cells culture</p>
Differential analysis of binarized single-cell RNA sequencing data captures biological variation
<p>Processed datasets used for binary differential analysis experiments.</p>
Figure 10 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 10 Normalize of transform of A. ZSM-5 Carrier only; B. Free GEF, and C. GEF-ZSM-5 loaded prepared by kneading method (ratio 1:1).
Figure 7 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 7 Drug release profile of free GEF and GEF from the loaded NPs for 60 min, phosphate buffer pH 6.8, apparatus II (paddle), 50 rpm, and 37 °C.
Figure 11 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 11 Control migration testing Treatment of A-549 cells with: Half-Maximal Inhibitory Concentration (IC50), IC50, 2 IC50, Double-Maximal.
Figure 8 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 8 Drug release profile of free GEF and GEF from the loaded NPs for 12 hr, phosphate buffer pH 6.8, apparatus II(paddle), 50 rpm, and 37 °C.
Figure 12 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 12 Colony test of untreated A-549 cells in a control. utilizing free gefitinib and ZSM- 5-gefitinib-loaded utilizing kneading technique 1:1 w/w, 12 IC50 stands for half dosage of the half maximum inhibitory concentration, IC50 for the half maximum inhibitory concentration, and 2 IC50 for double dose of the half maximum inhibitory concentration. Comparisons between each dosage and the control were made. The findings were shown as mean SD. The signs for statistical significance were *P 0.05, **P 0.01, and ***P 0.001.
Code for Nature Cell Biology manuscript (NCB-A50766)
Open the record for dataset details and reuse information.
Implementation of cell-free biological networks at steady state
<p>Living cells maintain a steady state of biochemical reaction rates by exchanging energy and matter with the environment. These exchanges usually do not occur in in vitro systems, which consequently go to chemical equilibrium. This in turn has severely constrained the complexity of biological networks that can be implemented in vitro. We developed nanoliter-scale microfluidic reactors that exchange reagents at dilution rates matching those of dividing bacteria. In these reactors we achieved transcription and translation at steady state for 30 h and implemented diverse regulatory mechanisms on the transcriptional, translational, and posttranslational levels, including RNA polymerases, transcriptional repression, translational activation, and proteolysis. We constructed and implemented an in vitro genetic oscillator and mapped its phase diagram showing that steady-state conditions were necessary to produce oscillations. This reactor-based approach will allow testing of whether fundamental limits exist to in vitro network complexity.</p>
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01369784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT00887640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging
ClinicalTrials.gov study NCT05254132. IPD Sharing: UNDECIDED. Countries: 0. Publications: 9.
Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00020722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biological Collection of Kidney Cells
ClinicalTrials.gov study NCT03364504. IPD Sharing: NO. Countries: 0. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.